Endometrial Neoplasms: all 1,347 studies
Page 3 of 14. Open to participants first (452), then studies with results posted, then the rest; newest registration first within each.
- Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine CancerRecruitingNCT06795009Phase 1
- Effect of Motivational Interviewing on Posttraumatic Stress Symptoms and Posttraumatic Growth in Women with Endometrial CancerNot yet recruitingNCT06781216Not applicable
- A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTBRecruitingNCT06781151
- A Phase 1 Study of LNCB74 in Advanced Solid TumorsRecruitingNCT06774963Phase 1
- Multimodal PET Imaging in the Diagnosis and Treatment of Pelvic TumorsRecruitingNCT06774209Not applicable
- Adebrelimab Plus Carboplatin/Paclitaxel Followed by Adebelizumab with or Without Apatinib in the Treatment of Advanced Recurrent/Metastatic Endometrial Cancer (A-CAPE): a Multicenter, Randomized, Controlled, Open-Label Clinical TrialNot yet recruitingNCT06771154Phase 2
- A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)RecruitingNCT06760819Phase 2
- A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid TumorRecruitingNCT06758557Phase 1/2
- A Study of DM002 in Patients With Advanced Solid TumorsRecruitingNCT06751329Phase 1/2
- QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial CancerNot yet recruitingNCT06751277Phase 2
- A Multi-center Prospective Study on the Oncological and Reproductive Outcomes and Quality of Life in Young Woman After Fertility-sparing Treatment of Endometrial Cancer and Endometrial Intraepithelial HyperplasiaNot yet recruitingNCT06745427
- A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic CancerRecruitingNCT06738966Phase 1
- Evaluation of Clinical and Molecular Biomarkers in Immunotherapy Treatment in Gynecologic CancerNot yet recruitingNCT06737640
- A Study of Lorigerlimab in Participants With Advanced Solid TumorsRecruitingNCT06730347Phase 2
- Akynzeo as Antiemetic Treatment in Patients With Endometrial CancerRecruitingNCT06726291Phase 4
- Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endometrial CancerRecruitingNCT06712472Phase 3
- Lynch Syndrome X-Talk of Enteral Mucosa With Immune SystemRecruitingNCT06708429
- A Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsRecruitingNCT06695845Phase 2
- Molecular Classification in Relation to Prevention of Endometrial Cancer Recurrence and Lifestyle FactorsRecruitingNCT06680791
- Single cEll pRofiling PErsistaNce To ImmuNothErapyRecruitingNCT06680739Phase 2
- Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic OriginRecruitingNCT06677190Phase 2
- MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial CancerRecruitingNCT06677112Not applicable
- Clinical Studies of Endometrial Cytology and Cervical Methylation Assays in Endometrial Cancer Screening and Fertility-Preservation EvaluationNot yet recruitingNCT06672341
- Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium CancerRecruitingNCT06656949Not applicable
- Clinicopathological Analysis of Endometrial Carcinoma in the View of Old and New International Federation of Gynecology and Obestetrics (FIGO)RecruitingNCT06632431
- BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial CancerNot yet recruitingNCT06620029Phase 1/2
- Implementation of Surgical Safety and Intraoperative Metastasis Identification Through Deep Learning: Multicentric Video Collection for Minimally Invasive Sentinel Lymph Node Dissection in Uterine MalignanciesRecruitingNCT06619002
- A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR PathwayNot yet recruitingNCT06614751Phase 1
- Collection of Endometrial Cancer-derived Organoids to Evaluate the Efficacy of PARP Inhibitors: PENDOR Pilot StudyRecruitingNCT06603506
- A Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsRecruitingNCT06586957Phase 1
- Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial CancerRecruitingNCT06584032Phase 3
- The Safety, Tolerability, and Efficacy of KD01 in Gynecologic MalignanciesRecruitingNCT06552598Phase 1
- PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial CancerRecruitingNCT06549855Not applicable
- Oral Topotecan With Toripalimab for Patients With Endometrial CancerNot yet recruitingNCT06548763Phase 2
- A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor AlphaRecruitingNCT06547840Phase 1
- Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical CancersRecruitingNCT06538337Not applicable
- A Phase 1 Trial of ERX-315 in Participants With Advanced Solid TumorsRecruitingNCT06533332Phase 1
- Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial CarcinomaRecruitingNCT06532539Phase 2
- A Study of XS-02 Capsules in Patients With Advanced Solid TumorsNot yet recruitingNCT06531486Phase 1/2
- A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer PatientsRecruitingNCT06522828Phase 2
- Translational Study of MSS, TP53 Mutation and Chromosome Instability Relationship in Endometrial CarcinomaNot yet recruitingNCT06521684
- Avelumab and M1774 in ARID1A-mutated Endometrial CancerRecruitingNCT06518564Phase 2
- A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid TumorsRecruitingNCT06515613Phase 1
- First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial CancerRecruitingNCT06502743Phase 2
- Pipelle® Under Ultrasound Guidance (PUG) to Investigate Post-menopausal Bleeding.RecruitingNCT06501846Not applicable
- EC_ItaLynch: Mainstreaming the Diagnosis of Lynch SyndromeNot yet recruitingNCT06501417
- A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.RecruitingNCT06481592Phase 2
- Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial CancerNot yet recruitingNCT06475599Phase 3
- Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial CancerRecruitingNCT06468215Not applicable
- Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial CancerRecruitingNCT06463028Phase 2
- Cancer Loyalty Card Study 2 (CLOCS-2)RecruitingNCT06447064
- INSPIRE: a Multi-Cancer Early Detection StudyRecruitingNCT06440018
- 3D Printed Custom Applicators for HDR BT (DISCO)RecruitingNCT06432478Not applicable
- Prospective Study for Endometrial Carcinoma and Hyperplasia in Childbearing-age WomenRecruitingNCT06417736Not applicable
- Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial CancerRecruitingNCT06413992Phase 2
- Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk WomenRecruitingNCT06409052
- POLE-END REAL LIFE: Endometrial Cancer Early Stages I-II and Advanced Stages III and IV Evaluation of POLE as a Prognostic Factor. Participants Are Women >= 18 Years Old, With the Pole MutationEnrolling by invitationNCT06409039
- A Study of Sofe-M in Participants With Selected Advanced Solid TumorsRecruitingNCT06400472Phase 1
- A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid MalignanciesRecruitingNCT06395519Phase 1/2
- GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer PatientsRecruitingNCT06379113Phase 2/3
- ALPINE: Maintenance Letrozole/AbemaciclibRecruitingNCT06366347Phase 2
- Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal BleedingRecruitingNCT06365905
- Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial CancerNot yet recruitingNCT06363708Not applicable
- a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial CancerRecruitingNCT06360653Not applicable
- Improving Endometrial Cancer Assessment by Combining Genomic Profiling and Surgical AssessmentRecruitingNCT06354738Not applicable
- Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformRecruitingNCT06349642
- Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial CancerRecruitingNCT06341855Not applicable
- A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerRecruitingNCT06340568Phase 3
- A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)RecruitingNCT06330064Phase 1/2
- Comparison of Five-year Survival and Disease-free Survival in Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With and Without Uterine ManipulatorRecruitingNCT06307886
- 177Lu-anti-PD-L1 sdAb in Metastatic Solid TumorsRecruitingNCT06305962Early Phase 1
- Myeloprotection With Trilaciclib in Pan-cancer PopulationNot yet recruitingNCT06297811Phase 2
- Vaginal Fluid Collection for Detection of Endometrial CancerRecruitingNCT06294886
- Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid TumorsRecruitingNCT06293898Phase 1
- The Gynecological Cancer Associated Thrombosis (GynCAT) StudyRecruitingNCT06284343
- Radiomics and Radiogenomics Models to Predict Molecular Integrated Risk Classes and Prognostic Factors in Endometrial Cancer.RecruitingNCT06279832Not applicable
- SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)RecruitingNCT06278857Phase 2
- Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid TumorsRecruitingNCT06276491Phase 1
- From Fetal-maternal Interface Immune Tolerance to Endometrial Cancer Immune Escape: Potential Targets for ImmunotherapyRecruitingNCT06273878
- A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid TumorsRecruitingNCT06270706Phase 1
- Detection of Endometrial Cancer Through Risk ModellingRecruitingNCT06268626
- Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial CancerRecruitingNCT06253494Phase 1/2
- Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of RecurrenceRecruitingNCT06250010
- A Study of MGC026 in Participants With Advanced Solid TumorsRecruitingNCT06242470Phase 1
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsRecruitingNCT06239194Phase 1/2
- HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of ChinaNot yet recruitingNCT06238284
- Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid TumorsRecruitingNCT06218914Phase 1
- Molecular Classification in Mexican Patients With Endometrial Cancer and Its Impact on PrognosisRecruitingNCT06206083
- A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsRecruitingNCT06172478Phase 2
- Effect of Stress Ball Use on Anxiety Level During Endometrial Biopsy ProcedureNot yet recruitingNCT06171581Not applicable
- Conservative Treatment for Atypical Endometrial Hyperplasia and Early Endometrial CancerNot yet recruitingNCT06170684
- Weight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing TreatmentRecruitingNCT06169449Not applicable
- Sentinel Lymph Node in Early-Stage Endometrium CancerRecruitingNCT06163963Not applicable
- Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsRecruitingNCT06128551Phase 1/2
- MRI Radiomics Combined With Pathomics on the Prediction of Molecular Classification and Prognosis of Endometrial CancerNot yet recruitingNCT06126393
- Endometrial Cancer Screening in High-risk PopulationsNot yet recruitingNCT06125886Not applicable
- Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial HyperplasiaRecruitingNCT06102863Phase 2
- Discovering New Targets for Colorectal and Endometrial Cancer Risk ReductionRecruitingNCT06096688
- Early Detection of Endometrial Cancer Using Plasma Cell-free DNA FragmentomicsRecruitingNCT06083779
- Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the EndometriumRecruitingNCT06073184Phase 2